Anthony H Nguyen
Examiner (ID: 17425)
Most Active Art Unit | 2854 |
Art Unit(s) | 3307, 2854, 2853 |
Total Applications | 2014 |
Issued Applications | 1600 |
Pending Applications | 48 |
Abandoned Applications | 337 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 7230892
[patent_doc_number] => 20040156909
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-12
[patent_title] => 'Polyvinylethers for delivery of polynucleotides to mammalian cells'
[patent_app_type] => new
[patent_app_number] => 10/772502
[patent_app_country] => US
[patent_app_date] => 2004-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7545
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20040156909.pdf
[firstpage_image] =>[orig_patent_app_number] => 10772502
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/772502 | Polyvinylethers for delivery of polynucleotides to mammalian cells | Feb 4, 2004 | Issued |
Array
(
[id] => 7127409
[patent_doc_number] => 20050059153
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Electromagnetic activation of gene expression and cell growth'
[patent_app_type] => utility
[patent_app_number] => 10/759526
[patent_app_country] => US
[patent_app_date] => 2004-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 18079
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10759526
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/759526 | Electromagnetic activation of gene expression and cell growth | Jan 15, 2004 | Abandoned |
Array
(
[id] => 7122882
[patent_doc_number] => 20050014711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-20
[patent_title] => 'Composition, formulations & methods for prevention and treatment of diseases and conditions associated with bronchoconstriction, allergy(ies) and inflammation'
[patent_app_type] => utility
[patent_app_number] => 10/758451
[patent_app_country] => US
[patent_app_date] => 2004-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 25712
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20050014711.pdf
[firstpage_image] =>[orig_patent_app_number] => 10758451
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/758451 | Composition, formulations & methods for prevention and treatment of diseases and conditions associated with bronchoconstriction, allergy(ies) and inflammation | Jan 13, 2004 | Abandoned |
Array
(
[id] => 7323497
[patent_doc_number] => 20040137449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-15
[patent_title] => 'Magnetic isolation and purification of nucleic acids'
[patent_app_type] => new
[patent_app_number] => 10/467495
[patent_app_country] => US
[patent_app_date] => 2004-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5974
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20040137449.pdf
[firstpage_image] =>[orig_patent_app_number] => 10467495
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/467495 | Magnetic isolation and purification of nucleic acids | Jan 8, 2004 | Abandoned |
Array
(
[id] => 5661034
[patent_doc_number] => 20060251630
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-09
[patent_title] => 'Encapsulated cell therapy'
[patent_app_type] => utility
[patent_app_number] => 10/540743
[patent_app_country] => US
[patent_app_date] => 2003-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 12918
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0251/20060251630.pdf
[firstpage_image] =>[orig_patent_app_number] => 10540743
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/540743 | Encapsulated cell therapy | Dec 23, 2003 | Abandoned |
Array
(
[id] => 7264978
[patent_doc_number] => 20040242514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Xenogenic oligo or/and polyribonucleotides as agents for the treatment of malignant tumours'
[patent_app_type] => new
[patent_app_number] => 10/481390
[patent_app_country] => US
[patent_app_date] => 2003-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2509
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20040242514.pdf
[firstpage_image] =>[orig_patent_app_number] => 10481390
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/481390 | Xenogenic oligo or/and polyribonucleotides as agents for the treatment of malignant tumours | Dec 17, 2003 | Abandoned |
Array
(
[id] => 7148062
[patent_doc_number] => 20040170615
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-02
[patent_title] => 'Methods and compositions using compounds from fetal cells and tissues to improve condition of skin'
[patent_app_type] => new
[patent_app_number] => 10/733150
[patent_app_country] => US
[patent_app_date] => 2003-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 28497
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20040170615.pdf
[firstpage_image] =>[orig_patent_app_number] => 10733150
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/733150 | Methods and compositions using compounds from fetal cells and tissues to improve condition of skin | Dec 9, 2003 | Abandoned |
Array
(
[id] => 274067
[patent_doc_number] => 07560231
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-07-14
[patent_title] => 'Mannitol and glucitol derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/729570
[patent_app_country] => US
[patent_app_date] => 2003-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 15663
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/560/07560231.pdf
[firstpage_image] =>[orig_patent_app_number] => 10729570
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/729570 | Mannitol and glucitol derivatives | Dec 4, 2003 | Issued |
Array
(
[id] => 7675320
[patent_doc_number] => 20040126798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-01
[patent_title] => 'Method for detecting transcription templates'
[patent_app_type] => new
[patent_app_number] => 10/728458
[patent_app_country] => US
[patent_app_date] => 2003-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10892
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0126/20040126798.pdf
[firstpage_image] =>[orig_patent_app_number] => 10728458
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/728458 | Method for detecting transcription templates | Dec 4, 2003 | Abandoned |
Array
(
[id] => 7432584
[patent_doc_number] => 20040209834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-21
[patent_title] => 'Antagonists of the oncogenic activity of the MDM2, and use thereof in the treatment of cancers'
[patent_app_type] => new
[patent_app_number] => 10/724225
[patent_app_country] => US
[patent_app_date] => 2003-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7378
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20040209834.pdf
[firstpage_image] =>[orig_patent_app_number] => 10724225
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/724225 | Antagonists of the oncogenic activity of the MDM2, and use thereof in the treatment of cancers | Nov 30, 2003 | Abandoned |
Array
(
[id] => 7426697
[patent_doc_number] => 20040229829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-18
[patent_title] => 'Enzyme inhibitors for metabolic redirection'
[patent_app_type] => new
[patent_app_number] => 10/723354
[patent_app_country] => US
[patent_app_date] => 2003-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 15412
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20040229829.pdf
[firstpage_image] =>[orig_patent_app_number] => 10723354
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/723354 | Enzyme inhibitors for metabolic redirection | Nov 24, 2003 | Abandoned |
Array
(
[id] => 330635
[patent_doc_number] => 07511131
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-03-31
[patent_title] => 'Antisense modulation of apolipoprotein B expression'
[patent_app_type] => utility
[patent_app_number] => 10/712795
[patent_app_country] => US
[patent_app_date] => 2003-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 66604
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/511/07511131.pdf
[firstpage_image] =>[orig_patent_app_number] => 10712795
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/712795 | Antisense modulation of apolipoprotein B expression | Nov 12, 2003 | Issued |
Array
(
[id] => 7469208
[patent_doc_number] => 20040102413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-27
[patent_title] => 'Method and reagent for the inhibition of telomerase enzyme'
[patent_app_type] => new
[patent_app_number] => 10/712672
[patent_app_country] => US
[patent_app_date] => 2003-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 48999
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0102/20040102413.pdf
[firstpage_image] =>[orig_patent_app_number] => 10712672
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/712672 | Method and reagent for the inhibition of telomerase enzyme | Nov 12, 2003 | Abandoned |
Array
(
[id] => 7377885
[patent_doc_number] => 20040220128
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => 'Nucleic acid based modulation of female reproductive diseases and conditions'
[patent_app_type] => new
[patent_app_number] => 10/712633
[patent_app_country] => US
[patent_app_date] => 2003-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 37389
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20040220128.pdf
[firstpage_image] =>[orig_patent_app_number] => 10712633
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/712633 | Nucleic acid based modulation of female reproductive diseases and conditions | Nov 12, 2003 | Abandoned |
Array
(
[id] => 5602221
[patent_doc_number] => 20060292566
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-28
[patent_title] => 'Method for optimising gene expressing using synonymous codon optimisation'
[patent_app_type] => utility
[patent_app_number] => 10/534130
[patent_app_country] => US
[patent_app_date] => 2003-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15443
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20060292566.pdf
[firstpage_image] =>[orig_patent_app_number] => 10534130
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/534130 | Method for optimising gene expressing using synonymous codon optimisation | Nov 9, 2003 | Abandoned |
Array
(
[id] => 5853221
[patent_doc_number] => 20060236412
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-19
[patent_title] => 'Porcine uroplakin ii promoter and the production method of useful proteins using said promoter'
[patent_app_type] => utility
[patent_app_number] => 10/532580
[patent_app_country] => US
[patent_app_date] => 2003-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8024
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0236/20060236412.pdf
[firstpage_image] =>[orig_patent_app_number] => 10532580
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/532580 | Porcine uroplakin II promoter and the production method of useful proteins using said promoter | Nov 3, 2003 | Issued |
Array
(
[id] => 7402281
[patent_doc_number] => 20040175362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-09
[patent_title] => 'Infectivity-enhanced conditionally-replicative adenovirus and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/697535
[patent_app_country] => US
[patent_app_date] => 2003-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 23820
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20040175362.pdf
[firstpage_image] =>[orig_patent_app_number] => 10697535
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/697535 | Infectivity-enhanced conditionally-replicative adenovirus and uses thereof | Oct 29, 2003 | Abandoned |
Array
(
[id] => 5892331
[patent_doc_number] => 20060277610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-07
[patent_title] => 'Construction of knockdown animal by transferring double-stranded rna expression vector'
[patent_app_type] => utility
[patent_app_number] => 10/533078
[patent_app_country] => US
[patent_app_date] => 2003-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 10199
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0277/20060277610.pdf
[firstpage_image] =>[orig_patent_app_number] => 10533078
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/533078 | Construction of knockdown animal by transferring double-stranded rna expression vector | Oct 28, 2003 | Abandoned |
Array
(
[id] => 7297295
[patent_doc_number] => 20040214800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-28
[patent_title] => 'Methods of using substituted tetracycline compounds to modulate RNA'
[patent_app_type] => new
[patent_app_number] => 10/692764
[patent_app_country] => US
[patent_app_date] => 2003-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 22203
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20040214800.pdf
[firstpage_image] =>[orig_patent_app_number] => 10692764
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/692764 | Methods of using substituted tetracycline compounds to modulate RNA | Oct 23, 2003 | Issued |
Array
(
[id] => 7220034
[patent_doc_number] => 20040072206
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-15
[patent_title] => 'Method for identifying modulators of transcription'
[patent_app_type] => new
[patent_app_number] => 10/433585
[patent_app_country] => US
[patent_app_date] => 2003-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8631
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20040072206.pdf
[firstpage_image] =>[orig_patent_app_number] => 10433585
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/433585 | Method for identifying modulators of transcription | Oct 16, 2003 | Abandoned |